Hennion & Walsh Asset Management Inc. Buys 44,700 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Hennion & Walsh Asset Management Inc. boosted its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report) by 90.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 94,182 shares of the company’s stock after acquiring an additional 44,700 shares during the period. Hennion & Walsh Asset Management Inc. owned approximately 0.25% of Crescent Capital BDC worth $1,742,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. bought a new stake in shares of Crescent Capital BDC during the second quarter valued at approximately $90,000. XTX Topco Ltd bought a new stake in Crescent Capital BDC in the 2nd quarter valued at $195,000. Alpine Global Management LLC acquired a new position in shares of Crescent Capital BDC in the 1st quarter valued at $217,000. Catalina Capital Group LLC bought a new position in shares of Crescent Capital BDC during the 2nd quarter worth about $220,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of Crescent Capital BDC during the 2nd quarter valued at about $346,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Stock Down 0.6 %

NASDAQ CCAP opened at $18.39 on Friday. The stock’s 50 day simple moving average is $18.42 and its 200 day simple moving average is $18.29. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.40 and a quick ratio of 1.40. Crescent Capital BDC, Inc. has a one year low of $15.03 and a one year high of $19.63. The firm has a market cap of $681.57 million, a PE ratio of 6.54 and a beta of 0.81.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last announced its earnings results on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. The company had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same period last year, the company posted $0.56 earnings per share. As a group, sell-side analysts forecast that Crescent Capital BDC, Inc. will post 2.35 earnings per share for the current fiscal year.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.14%. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Monday, September 30th. Crescent Capital BDC’s dividend payout ratio is presently 59.79%.

Wall Street Analyst Weigh In

A number of research analysts have commented on CCAP shares. Wells Fargo & Company cut their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 14th. LADENBURG THALM/SH SH initiated coverage on Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 target price for the company. Finally, Bank of America dropped their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $19.00.

View Our Latest Analysis on Crescent Capital BDC

Crescent Capital BDC Company Profile

(Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report).

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.